How Tools And Technologies Bring Advanced Therapies To Market
Source: Pall Corporation
Featuring Clive Glover, General Manager, Gene Therapy, at Pall, and James Taylor, co-founder and GM, Precision NanoSystems
Clive Glover, General Manager, Gene Therapy, at Pall and James Taylor, co-founder and GM, Precision NanoSystems, discuss how their combined expertise can help drug developers get exciting genomic medicines to patients.
VIEW THE Q&A!
Log In
Signing up provides unlimited access to:
Free Sign Up
Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of BioProcess Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Pall Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more